Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase NA 1Phase EARLY_PHASE1 1Phase 3 1Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Polycystic Ovary Syndrome 3Insulin Resistance 3Sleep Apnea, Obstructive 1Metabolic Syndrome 1Glucose Intolerance 1Diabetes Mellitus, Type 2 1Carotid Intimal Medial Thickness 1 1

Interventions

Metformin 6Pioglitazone 3drospirenone and ethinyl estradiol combination 1Sugars 1Sodium-Glucose Transporter 2 Inhibitors 1Sitagliptin Phosphate 1Simvastatin 1Leuprolide 1Insulin Glargine 1Insulin 1Injections 1Fenofibrate 1Estrogens 1DNA, Ribosomal 1Continuous Positive Airway Pressure 1Canagliflozin 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Insulin Resistance × Pioglitazone × Clear all
NCT00203996 2023-03-21

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

University of Chicago

Phase 4 Terminated
37 enrolled 15 charts

Insulin Resistance, Polycystic Ovary Syndrome, Glucose Intolerance, Sleep Apnea, Obstructive, Metabolic Syndrome

NCT01223196 2016-01-11

PIO-TACE

The University of Texas Health Science Center at San Antonio

Phase 4 Completed
60 enrolled 8 charts

Diabetes Mellitus, Type 2, Insulin Resistance

NCT00145340 2008-09-26

Pioglitazone Treatment in Polycystic Ovary Syndrome

Odense University Hospital

Phase 4 Completed
30 enrolled

Carotid Intimal Medial Thickness 1, Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡